Conference Coverage

VIDEO: Move beyond BMI to see obesity as a disease


 

REPORTING FROM AACE 2018

The five medications approved for chronic management of obesity all have been shown to be safe and effective in clinical trials. But they have different mechanisms of action, different side effect profiles, and different warnings and precautions, Dr. Garvey noted.

Understanding the pharmacology of all five drugs is important to help a specific patient achieve the best outcomes.

“There’s no drug that can be recommended, in a hierarchical sense, as being better than any others across the board in all patients,” Dr. Garvey explained. “We really need to individualize therapy based on their side effect profile and their types of complications that present with the patient.”

Recommended Reading

VIDEO: Intestinal remodeling contributes to HbA1c drop after Roux-en-Y gastric bypass
MDedge Internal Medicine
Being overweight as a child increases the risk of developing diabetes
MDedge Internal Medicine
Life and health are not even across the U.S.
MDedge Internal Medicine
CVD risk high in individuals who once had metabolically healthy obesity
MDedge Internal Medicine
MDedge Daily News: Physician burnout needs more than yoga
MDedge Internal Medicine
Sucralose sparks appetite in obese, not lean, individuals
MDedge Internal Medicine
Obesity and weight loss both linked to RA disability
MDedge Internal Medicine
Figure-of-eight overstitch keeps endoscopic stents in place
MDedge Internal Medicine
VIDEO: BMI helps predict bone fragility in obese patients
MDedge Internal Medicine
Trends in teen consumption of sports drinks are up and down
MDedge Internal Medicine